|
|
|
|
|
|
|
Arrowhead Pharma (ARWR)
|
|
6.85 -0.12 (-1.72%)
|
04-23 16:00
|
|
Open:
|
7
|
Pre. Close:
|
6.97
|
|
High:
|
7.0202
|
Low:
|
6.735
|
|
Volume:
|
877,850
|
Market Cap:
|
594M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
7.03 - 7.066
|
7.066 - 7.095
|
|
Low:
|
6.66 - 6.697
|
6.697 - 6.727
|
|
Close:
|
6.796 - 6.854
|
6.854 - 6.902
|
|
|
|
Technical analysis (as of: 2018-04-23 4:27:11 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 8.63 One year: 9.45
|
|
Support:
|
Support1: 6.26 Support2: 5.21
|
|
Resistance:
|
Resistance1:
7.39 Resistance2: 8.09
|
|
Pivot:
|
6.89 
|
|
Moving Averages:
|
MA(5): 6.93  MA(20): 6.90
MA(100): 5.67 MA(250): 3.79
|
|
MACD:
|
MACD(12,26):
0.04 Signal(12,26,9): 0.06
|
|
%K %D:
|
%K(14,3): 57.43 %D(3): 57.26
|
|
RSI:
|
RSI(14): 49.25
|
|
52-Week:
|
High: 8.09
Low: 1.42 Change(%): 350.7
|
|
Average Vol(K):
|
3-Month: 139815
10-Days 92775
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ARWR has closed above bottom band by 46.3%. Bollinger Bands are 28.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-13T11:46:25-04:00
Arrowhead Pharmaceuticals: Sneaky Upside Present Over The Course Of 2018
2018-04-11T09:21:26-04:00
Premarket Gainers as of 9:05 am (04/11/2018)
2018-04-11T08:04:55-04:00
Arrowhead's lead candidate shows encouraging action in HBV extension study; shares up 9% premarket
2018-04-11T07:00:00-04:00
Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress(TM)
2018-04-06T14:59:28-04:00
RNAi For Hepatitis B - A False Hope For A Cure?
2018-03-31T09:55:20-04:00
Week 14 Breakout Forecast: Short-Term Picks To Give You An Edge
2018-03-28T07:30:00-04:00
Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress(TM)
2018-03-27T08:20:36-04:00
Premarket analyst action - healthcare
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
